Clinical Trial

Transcranial Photobiomodulation in Anxiety Disorders

Recruiting
View on ClinicalTrials.gov →
Summary
The investigators have previously shown that safe, non-invasive methods of brain stimulation such as the administration of transcranial infrared light can result in improvements to cognition and emotion. The investigators hypothesize that transcranial photobiomodulation (tPBM) can be used in conjunction with attention bias assessment and modification to reduce anxiety symptoms in individuals with sub-clinical anxiety.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-13.
Status change: Not Yet Recruiting → Recruiting 2026-05-11
Trial Details
NCT Number NCT07133893
Lead Sponsor Francisco Gonzalez-Lima, PhD
Conditions Symptoms of Anxiety
Enrollment 280 participants
Start Date 2025-09-01
Primary Completion 2027-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2026-05-14